• Skip to content
  • skip to navigation
AstraZeneca logo AstraZeneca logo
AstraZeneca logo AstraZeneca logo
  • What science can do
    • What science can do
    • LabTalk blog
    • Our technology
    • Drug modalities
    • Artificial Intelligence
  • Our science
    • Our science
    • Pipeline
    • Publications
    • Cambridge
    • Gothenburg
    • Gaithersburg
  • Our therapy areas
    • All therapy areas
    • Oncology
    • Cardiovascular, Renal and Metabolism
    • Respiratory
    • Other disease areas
    • All medicines
  • Our company
    • Our company
    • Our strategy
    • Our people
    • Leadership team
  • Careers
    • Careers
    • Global careers site
  • Investors
    • Investor Relations (Global) UK flag
    • Investor Relations (Sweden) Swedish flag
    • Stock Exchange announcements
    • Results and presentations
    • Annual Reports
    • Governance
    • Shareholder information
    • Dividend policy
    • Key facts
    • FAQs
    • Debt Investors
    • ADR Programme
  • Media
    • Press Releases
    • Media centre
    • Articles
    • Image library
    • Broadcast videos
    • Archive
  • Sustainability
    • Sustainability
    • Access to healthcare
    • Environmental protection
    • Ethics and transparency
    • Resources
  • Partnering
    • Partnering with AstraZeneca
    • Our Partnering teams
    • Our areas of partnering interest
    • Why partner with AstraZeneca?
    • Secrets to successful partnering
  • AstraZeneca Websites
  • Global site
  • Our company
  • Our strategy
  • Our people
  • Leadership team

Our people

I’m inspired by the fact that my colleagues and I can make a real difference. Our work brings value to AstraZeneca and our partners and most importantly, can have a positive impact on the lives of patients.

Åsa Sjöholm Timén, PhD, Associate Transaction Director, Business Development Operations

View Åsa's profile

Our people

"AstraZeneca’s entrepreneurial and evidence-based culture encourages us to recognise where successful innovation may require collaborating or licensing. This approach enables us to push the boundaries of science by maximising the utility of our resources, ultimately increasing the benefit to patients".

Associate Transaction Director, Business Development Operations

View Umaima's profile

Our people

"I feel privileged to work with, lead and learn from so many excellent professionals in the areas of science, operations and business, both within AstraZeneca and externally with our partners. Adaptability is a key ability in an environment with an intrinsic level of uncertainty and continued regulatory and legal changes."

Andrea Burgos Prieto, Associate Director Alliance & Integration Management, Business Development Operations

View Andrea's profile

Our people

“Partnering is about bringing together the most talented people with different backgrounds to solve complex tasks, which I find very rewarding. In my role, I am fortunate to experience many different aspects of AstraZeneca’s business and how it all fits together. The energy within these walls is remarkable.”

Fredrik Röök, Transaction Director, Business Development Operations

View Fredrik's profile

Our people

"What drives me the most is solving difficult problems, in collaboration with others, for the benefit of the patient and the business."

Mark Fielding, Associate Principal Scientist, Global Medicines Development

View Mark's profile

Our people

"There is an expanding universe of biological data available which can revolutionise our understanding of disease and therapy if we find innovative ways to share and explore it."

Jonathan Dry, Director, Bioinformatics and Data Science, Research and Early Development, Oncology R&D

View Jonathan's profile

Our people

"I believe personalised healthcare is the future of medicine; it allows us to use the latest diagnostic science to target medicines to patients most likely to benefit."

Senior Vice-President of Precision Medicine, R&D Oncology

View Ruth's profile

Shawn Davis

Head of Drug Delivery, BioPharmaceuticals Development, R&D

Anand Subramony

Vice President, Antibody Discovery and Protein Engineering, R&D

Richard Marshall

Senior Vice President and Global Head of Respiratory, Inflammation and Autoimmunity Late Stage Development, BioPharmaceuticals R&D

Annette Bak

Head of Advanced Drug Delivery, Pharmaceutical Sciences, R&D

Marianne Ashford

Senior Principal Scientist, Advanced Drug Delivery, Pharmaceutical Sciences, R&D

Alan Sabirsh

Principal Scientist, Advanced Drug Delivery, Pharmaceutical Sciences, R&D

Lennart Lindfors

Adjunct Professor and Principal Scientist, Advanced Drug Delivery, Pharmaceutical Sciences, R&D

Sara Richardson

New Modality CMC Analytics Team Lead, Advanced Drug Delivery, Pharmaceutical Sciences, R&D

Arpan Desai

Associate Principal Scientist, Advanced Drug Delivery, Pharmaceutical Sciences, R&D

Sanya Puri

Associate Director, Advanced Drug Delivery, Pharmaceutical Sciences, R&D

David Geleta

Data Scientist

Anna Coenen Stass

Senior Scientist, Bioinformatics, Research and Early Development, Oncology R&D


Jim Weatherall

Vice President, Data Science & AI, R&D

Simon Bradford

Data & Analytics Enabling Units Engineering Lead

Esben Jannik Bjerrum

Principal Scientist, Cheminformatics, Discovery Sciences, R&D

Ashiq Ariff

Data Scientist


Chris Kenny

Senior Information Architect

Åsa Sjöholm Timén, PhD

Associate Transaction Director, Business Development Operations

Marie-José (MJ) Hoellinger, MD, MBA

Global Medicine Leader and Vice President, Lokelma & Bydureon

Joris Silon

Senior Vice President, Global Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals Business Unit


Habib Bennaceur

Global Vice President, Oral Diabetics

Anders Broo

Head of Data Science and Modelling, Pharmaceutical Sciences, R&D

Miriam Guest

Associate Principal Scientist, Microbiology, Pharmaceutical Technology and Development

Jason Snape

Global Safety, Health and Environment Director and Senior Principal Environmental Scientist


Elisabeth Björk

SVP, Late Cardiovascular, Renal and Metabolism (CVRM)

John Houghton

Global Medicine Leader

Lutz Jermutus

Head of Projects

Kirsha Naicker

Global Study Medical Scientist Leader, Immuno-oncology


Rodrigo Gribble Escobar

Vice President, Cardiovascular

Anna Sundgren

Global Development Leader, Lokelma & Bydureon

Rahul Agrawal

Global Medicines Leader, Cardiovascular

José Baselga

Executive Vice-President, Research & Development Oncology


Andrea Burgos Prieto

Associate Director Alliance & Integration Management, Business Development Operations

Garry Pairaudeau

Head of Hit Discovery, Discovery Sciences, R&D

Ola Engkvist

Associate Director, Computational Chemistry, Discovery Sciences, R&D

Clive Green

Executive Director and Head of Global Sample Management, Discovery Sciences, R&D


Maria Belvisi

Senior Vice President and Head of Research and Early Development, Respiratory, Inflammation and Autoimmunity, BioPharmaceuticals R&D

Tom Keith-Roach

Therapy Area Vice President, Respiratory
 

Ralph Knöll

Chief Scientist, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D

Susan Galbraith

Senior Vice President and Head of Research and Early Development, Oncology R&D


Qing-Dong Wang

Senior Principal Scientist, Bioscience, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D

David Keeling

Senior Project Leader, Research and Early Development, Respiratory, Inflammation & Autoimmunity, BioPharmaceuticals R&D

Katerina Pardali

Associate Principal Scientist, Respiratory, Inflammation & Autoimmunity, IMED Biotech Unit

Stephen Delaney

Team Leader, Research and Early Development, Respiratory, Inflammation & Autoimmunity (RIA), BioPharmaceuticals R&D

Regina Fritsche-Danielson

SVP, Early Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D

View Regina's profile

Jonathan Dry

Director, Bioinformatics and Data Science, Research and Early Development, Oncology R&D

View Jonathan's profile

Ruth March

Senior Vice-President of Precision Medicine, R&D Oncology

View Ruth's profile


Li-Ming Gan

Head of Early Clinical Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D

Shaun Grady

Vice-President Business Development Operations

Maria Groves

Associate Director, Head of the Cancer Research UK – AstraZeneca Antibody Alliance Laboratory (CAZAAL)

Mark Fielding

Associate Principal Scientist, Global Medicines Development

William Dall’Acqua

Vice President, Antibody Discovery and Protein Engineering, R&D

Mark O’Connor

Chief Scientist, Oncology, IMED Biotech Unit

Slavé Petrovski

VP and Head of Genome Analytics & Bioinformatics, Centre for Genomics Research, Discovery Sciences, R&D

Paul Harper

Principal Scientist, Discovery Sciences, R&D


Menelas Pangalos

Executive Vice-President, BioPharmaceuticals R&D

View Menelas's profile

Fredrik Röök

Transaction Director, Business Development Operations

View Fredrik's profile


Elisa Lázaro Ibáñez

Postdoctoral Researcher, Discovery Biology, Discovery Sciences, R&D, AstraZeneca

Per Lindblom

Director, Global Project Management

Ella Ekholm

Senior Medical Lead, Late-stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D

Ramon Nogueras

Regional Director EMEA, Global Real Estate


Kumar Srinivasan

Vice President and Global Head of Business Development and Licensing, BioPharmaceuticals R&D, AstraZeneca

Helen Angell

Principal Scientist, Oncology, Translational Sciences, IMED Biotech Unit

Emma Dean

Director, Early Phase Oncology, Early Clinical Development, IMED Biotech Unit

Amy Taylor

Business Planning & Operations Director, Chief Operating Office, BioPharmaceuticals R&D


Christopher J. Rhodes

Chief Scientist, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, and Chair of AstraZeneca’s postdoc programme

Nicolas Jose Guzman

Director Physician, Nephrology Clinical Research

Herren Wu

Senior Vice President and Head of Antibody Discovery and Protein Engineering (ADPE), R&D

Umaima Ahmad

Associate Transaction Director, Business Development Operations






Our focus areas

Cardiovascular, Renal and Metabolism

Oncology

Respiratory

Inflammation and Autoimmunity

Neuroscience

Infection and Vaccines


AstraZeneca Websites

This website is intended for people seeking information on AstraZeneca's worldwide business. Our country sites can be located in the AZ Network.




Veeva ID: Z4-8411
Date of next review: August 2020

Resources

  • All resources
  • Open Innovation
  • Externally sponsored scientific research
  • Medical Information for HCPs
  • US prescription assistance programmes
  • Global clinical trials information
  • Medicines
  • Report a possible side effect
  • Pearl Therapeutics

Quick links

  • Media
  • Investor Relations
  • Partnering
  • Careers
  • Sustainability
  • Modern Slavery Statement
  • Supplier information
  • Social Media Community Guidelines

Social Media

  • LinkedIn
  • Twitter
  • YouTube
  • Instagram
  • Glassdoor
  • Facebook

utility links

  • Legal notice and Terms of Use
  • Privacy notice
  • Cookie policy
  • Site map
  • Contact us

© AstraZeneca 2020

You are now leaving AstraZeneca.com

You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents.

AstraZeneca provides this link as a service to website visitors. AstraZeneca is not responsible for the privacy policy of any third party websites. We encourage you to read the privacy policy of every website you visit.

Click ‘cancel’ to return to AstraZeneca’s site or ‘continue’ to proceed.

Cancel Continue
?

Important notice for users

You are about to access AstraZeneca historic archive material. Any reference in these archives to AstraZeneca products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data or safety data. Please refer to your approved national product label (SmPC) for current product information.

I have read this warning and will not be using any of the contained product information for clinical purposes.

I disagree I agree
?
?